Search at Vanderbilt-Ingram Cancer Center

1193 results found

TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

Relevance: 1

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Relevance: 1

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Relevance: 1

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

Relevance: 1

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

Relevance: 1

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Relevance: 1

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

Relevance: 1

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Relevance: 1

A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)

Relevance: 1

N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

Relevance: 1